MRNAON
MRNAON is the Ondo tokenized version of Moderna, Inc., a biotechnology firm, is dedicated to the discovery, development, and commercialization of messenger RNA (mRNA) based therapies and preventive medicines. Its extensive research and development efforts target a broad spectrum of medical needs, including infectious diseases, cancer immunology, rare conditions, cardiovascular ailments, and autoimmune disorders, with operations spanning the United States, Europe, and other global markets. The company's diverse product pipeline encompasses various vaccine candidates: those for respiratory illnesses, latent viral infections and public health threats. Additionally, Moderna is advancing systemic secreted and cell surface-targeted therapeutics, an array of cancer vaccines (including personalized, KRAS, and checkpoint varieties), intratumoral immuno-oncology products, localized regenerative treatments, systemic intracellular medicines, and inhaled pulmonary solutions.
Name MRNAON
Rank No.
Market Cap $0.00
Fully Diluted Market Cap $0.00
Market Share %
Trading Vol/Market Cap (24H) 0
Circulation Supply --
Max Supply 0
Total Supply --
Circulation Rate %
Issue Date --
The price at which the asset was first issued --
All-Time High ,
Lowest Price ,
Public Blockchain MRNAON
Introduction MRNAON is the Ondo tokenized version of Moderna, Inc., a biotechnology firm, is dedicated to the discovery, development, and commercialization of messenger RNA (mRNA) based therapies and preventive medicines. Its extensive research and development efforts target a broad spectrum of medical needs, including infectious diseases, cancer immunology, rare conditions, cardiovascular ailments, and autoimmune disorders, with operations spanning the United States, Europe, and other global markets. The company's diverse product pipeline encompasses various vaccine candidates: those for respiratory illnesses, latent viral infections and public health threats. Additionally, Moderna is advancing systemic secreted and cell surface-targeted therapeutics, an array of cancer vaccines (including personalized, KRAS, and checkpoint varieties), intratumoral immuno-oncology products, localized regenerative treatments, systemic intracellular medicines, and inhaled pulmonary solutions.
Sector
- common.mc-trade-zone-xStocks
Social Media
Fund Flow Analysis
|
Buy(MRNAON) |
Sell(MRNAON) |
Net Inflow |
| Big |
0.000 |
0.000 |
0.000 |
| Medium |
8.761K |
3.991K |
4.770K |
| Small |
21.740K |
14.622K |
7.118K |
| Total |
30.501K |
18.614K |
11.887K |
Disclaimer: Data provided by and should not be considered as investment advice.
